Production (Stage)
SBC Medical Group Holdings Incorporated
SBC
$4.55
$0.7118.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.63% | -54.41% | -66.10% | 73.25% | 212.50% |
| Total Depreciation and Amortization | -38.31% | -63.59% | -69.02% | -76.94% | -63.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.47% | -13.31% | 30,780.99% | -172.54% | 16.71% |
| Change in Net Operating Assets | -39.45% | -533.75% | -225.65% | 109.06% | -356.64% |
| Cash from Operations | -47.62% | -126.16% | -78.38% | 618.31% | 12.46% |
| Capital Expenditure | -7.50% | 91.33% | 6.78% | 16.87% | -110.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -98.45% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.83% | 620.35% | -13.01% | -371.10% | 13.45% |
| Cash from Investing | 71.16% | 33.75% | -68.99% | -369.69% | -36.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -634.83% | -453.22% | 98.92% | 99.37% | 96.64% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 14.07% | -- | -- |
| Cash from Financing | -597.51% | 9,047.64% | 77.07% | 98.67% | -100.83% |
| Foreign Exchange rate Adjustments | 189.46% | -354.45% | 2,505.02% | -743.88% | 34.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 202.49% | -148.25% | -19.13% | 169.40% | -33.29% |